Researchers invent method to unlock potential of widely used drug

March 20, 2020

Sugars like polysaccharides are found everywhere in nature and are believed to be essential for life to arise. In humans, they cover the surface of all cells and the family of polysaccharides called GAGs (glycosaminoglycans) are particularly abundant and difficult to analyse.

GAGs of the heparan sulfate type play key roles in regulating many biological functions, including inflammation, neurodegeneration and tumor metastasis. In fact, a special type of heparan sulfate called heparin is currently one the most used drugs in the clinic where it is used to prevent coagulation. Researchers are therefore intensively trying to map the detailed structures of heparan sulfates and link them to their biological functions.

So far, only a few structures have been successfully identified, but that may be about to change. In a new study in Nature Communications from the Danish National Research Foundation Centre for Glycomics at the Department of Cellular and Molecular Medicine, University of Copenhagen, Rebecca and her team has invented a new method that will boost the mapping of these structures.

"Determining the structures is a key question in the research about sugars. If we know the structure, we can determine what the cues are for specific biological functions and consider potential ways to exploit this in the development of therapeutics. This is hugely important and clinically relevant, as shown by the widely used anti-coagulant heparins, and the potential application of new heparin-based drugs for multiple diseases in the future," says Dr Rebecca Louise Miller, corresponding author of the new study and Assistant Professor at the Copenhagen Center for Glycomics.

A new technology and new EU funding

The researchers' new method is called "Shotgun ion mobility mass spectrometry sequencing" or SIMMS2. The technique relies on advanced mass spectrometry to break the sugar structures into smaller fragments, separate them, and fingerprint them compared to known standards. Virtual reassembly of the sugar pieces into a picture of the original sugar like a big jigsaw puzzle - only infinitely more complicated - can for the first time determine larger sequences of polysaccharides that are big enough to capture the cues that direct functions like anti-coagulation.

"The instrumentation behind this new method was invented by the company Waters Ltd in 2006 and is available to many pharmaceutical companies and researchers. This means that the method could be easily implemented and widely used for drug discovery by many research groups in a short period of time," says Professor Jeremy Turnbull, University of Liverpool and Copenhagen Center for Glycomics, a co-author on the study.

The GAG team at Copenhagen Center of Glycomics recently reported the first cell-based method (GAGOme) to produce all variants of GAGs for discovery of functions and development of therapeutics (Chen et al, Nature Methods 2018), and this will be combined with the new method for sequencing of GAG structures. The hope is to follow up on many promising therapeutic effects of heparins in cancer and neurogenerative diseases and pioneer new use of GAGs in medicine.

To continue the development of the SIMMS method and pioneer new use of GAGs in medicine, Miller and Turnbull were recently awarded an EU grant worth €3.8m to a consortium that also includes researchers from Freie Universität Berlin, University of Utrecht, University of Liverpool and Karolinska Institutet in Stockholm. They will also apply the method to understand heparan sulfate structural cues that regulate stem cells to generate specialized neurons for treatment of Parkinson's disease.
Read the entire study in Nature Communications: "Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides".

The work was carried out in collaboration with researchers at the Freie Universität Berlin in Germany, and the Universities of Oxford and Liverpool in the UK.

University of Copenhagen The Faculty of Health and Medical Sciences

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to